Herpes Simplex Virus as a Cause of Stevens-Johnson Syndrome
Yes, herpes simplex virus (HSV) can cause Stevens-Johnson Syndrome (SJS), particularly in children, and is recognized as an important infectious trigger of this severe mucocutaneous reaction. 1
Relationship Between HSV and SJS
Infectious Triggers of SJS
- HSV is specifically identified in multiple guidelines as a known infectious trigger for SJS/TEN 1
- While medications are the most common cause of SJS/TEN in adults, infections are more frequently implicated in children, with up to 50% of pediatric cases attributed to infectious causes 1
- HSV joins Mycoplasma pneumoniae as one of the most frequently documented infectious causes of SJS 2, 3
Clinical Distinction
- It's important to distinguish between:
- Erythema multiforme major (EMM): Typically caused by HSV and predominantly affects the extremities with typical target lesions 1
- SJS: More severe reaction with widespread purpuric macules or flat atypical targets and less than 10% body surface area (BSA) involvement 1
- SJS/TEN overlap: 10-30% BSA involvement 1
- TEN: Greater than 30% BSA involvement 1
Diagnostic Considerations
Clinical Features
- SJS presents with:
- Widespread purpuric macules or flat atypical targets
- Mucosal involvement (often severe)
- Epidermal detachment (<10% BSA in SJS)
- Prodromal symptoms including fever, malaise, and respiratory symptoms 1
Histopathology
- Skin biopsy shows:
- Variable epidermal damage ranging from individual cell apoptosis to confluent epidermal necrosis
- Basal cell vacuolar degeneration
- Subepidermal vesicle or bulla formation
- Mild perivascular infiltrate of lymphocytes and histiocytes 1
Testing for HSV
- When HSV is suspected as a trigger:
- PCR testing of vesicular fluid
- Serological testing for HSV antibodies
- Testing for other potential infectious triggers (particularly M. pneumoniae) should be performed concurrently 1
Management of HSV-Associated SJS
Immediate Actions
- Prompt recognition and early intervention are critical 2
- Discontinue any potential triggering medications 1
- Initiate antiviral therapy (acyclovir) when HSV is identified or strongly suspected 4, 5
Treatment Approach
- Supportive care remains the cornerstone of management:
Prevention of Recurrence
- HSV-associated SJS has been documented to recur in some patients 4, 5
- Prophylactic strategies for patients with recurrent HSV-associated SJS include:
Special Considerations in Children
- SJS recurrence is more common in children (up to 18% of cases) 2
- Children with HSV-associated SJS should be managed in age-appropriate specialist units 1
- Prophylactic antiviral therapy may be considered in children with recurrent HSV-associated SJS 2
Prognosis and Complications
- Mortality rates vary: 1-5% for SJS, 25-35% for TEN 3
- Long-term sequelae may include:
HSV-associated SJS requires prompt recognition, immediate treatment with antivirals when indicated, and comprehensive supportive care to minimize morbidity and mortality. For patients with recurrent HSV-associated SJS, prophylactic strategies should be strongly considered to prevent future episodes.